Liver Cirrhosis in Erythropoietic Protoporphyria: Improvement of Liver Function With Ursodeoxycholic Acid

Pirlich, Matthias; Lochs, Herbert; Schmidt, Hartmut H.-J.
December 2001
American Journal of Gastroenterology;Dec2001, Vol. 96 Issue 12, p3468
Academic Journal
Presents a letter to the editor on the effects of ursodeoxycholic acid on a patient with liver cirrhosis and erythropoietic protoporphyria.


Related Articles

  • The Long-term Beneficial Effects of Ursodeoxycholic Acid in Primary Biliary Cirrhosis are Highly Questionable. Gong Yan; Erik, Christensen; Gluud, Christian // American Journal of Gastroenterology;Feb2007, Vol. 102 Issue 2, p464 

    A letter to the editor is presented in response to article about the long-term effects of ursodeoxycholic acid on people with primary biliary cirrhosis.

  • Use of ursodeoxycholic acid in the treatment of arteriohepatic dysplasia. Kay, Marsha H.; Wyllie, Robert // Clinical Pediatrics;Nov1996, Vol. 35 Issue 11, p593 

    Focuses on the use of ursodeoxycholic acid as a cholesterol-lowering agent in two patients with arteriohepatic dysplasia. Patient reports.

  • Effect of Ursodeoxycholic Acid Administration in Patients with Primary Hypercholesterolaemia. Cicognani, C.; Malavolti, M.; Morselli-Labate, A.M.; Talarico, R.; Zamboni, L.; Sama, C. // Clinical Drug Investigation;1999, Vol. 18 Issue 4, p263 

    Objective: A high plasma cholesterol level is a major predisposing factor for coronary artery disease, and new treatments are currently under consideration. Supported by the close relationship between cholesterol and bile acid metabolism, recent studies have reported a hypocholesterolaemic...

  • Ursolic Acid of Origanum majorana L. Reduces Aβ-induced Oxidative Injury. Ho-Jin Heo; Hong-Yon Cho; Bumshik Hong; Hye-Kyung Kim; Tae-Ryeon Heo; Eun-Ki Kim; Sung-Koo Kim; Chang-Ju Kim; Dong-Hoon Shin // Molecules & Cells (Springer Science & Business Media B.V.);2002, Vol. 13 Issue 1, p5 

    Presents a study that investigated the effect of ursolic acid from Origanum majorana L. on A beta-induced neurotoxicity. Methodology; Results; Discussion.

  • Ursodeoxycholic acid and primary biliary cirrhosis. Lim, A.G.; Northfield, T.C. // BMJ: British Medical Journal (International Edition);8/20/94-8/27/94, Vol. 309 Issue 6953, p491 

    Focuses on the use of ursodeoxycholic acid in primary biliary cirrhosis. Effects of the drug on the pathophysiology of the disease; Decrease in the retention of bile acids; Reduction in the damage caused by hydrophobic bile acids.

  • Gallstone drug also prevents formation during rapid weight loss.  // Modern Medicine;Aug94, Vol. 62 Issue 8, p20 

    Reports on the use of the drug Ursodiol (ursodeoxycholic acid) in gallstone formation during rapid weight loss. Toleration to the drug; Adverse effects; Dosage.

  • A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations. Huawei Zhang; Sainan Li; Jing Yang; Yuanyuan Zheng; Jianrong Wang; Wenxia Lu; Yuqing Zhou; Qin Yin; Rong Zhu; Chuanyong Guo // Gastroenterology Review / Przeglad Gastroenterologiczny;2015, Vol. 10 Issue 3, p148 

    In this study, a meta-analysis of randomised controlled trials that compared ursodeoxycholic acid (UDCA) monotherapy with therapies combining UDCA and corticosteroids was performed. We found that combination therapy with UDCA and corticosteroids was more effective than UDCA monotherapy for...

  • Tissue transplantation.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS107 

    Presents an abstract of the research manuscript `Hepatocellular carcinoma in ursodeoxycholic acid treated primary biliary cirrhosis,' by J. Turner et al.

  • Ursodiol for Hepatobiliary Disorders. Rubin, Raymond A.; Kowalski, Thomas E.; Khandelwal, Mukul; Malet, Peter F. // Annals of Internal Medicine;8/1/94, Vol. 121 Issue 3, p207 

    Purpose: To explain the rationale supporting the use of ursodiol (ursodeoxycholic acid) for the treatment of patients with cholesterol gallstones and chronic liver diseases and to describe the results obtained in clinical trials. Data Sources: Personal databases of the authors and MEDLINE were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics